Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Generex Biotechnology Corp (GNBT)

OTC Markets
Currency in USD
Disclaimer
0.001
0.000(0.00%)
Closed
Trading near 52-week Low
Fair Value
Unlock Value
Day's Range
0.0010.001
52 wk Range
0.0010.050
Prev. Close
0.001
Open
0.001
Day's Range
0.001-0.001
52 wk Range
0.001-0.05
Volume
0
Average Vol. (3m)
7,875
1-Year Change
0%
Shares Outstanding
122,058,444
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about GNBT?
Vote to see community's results!
or

Generex Biotechnology Corp Company Profile

Generex Biotechnology Corporation is a life science holding company. The Company is engaged in pharmaceutical and biotechnological research and development and other activities. Its subsidiary, NuGenerex Immuno-Oncology, Inc., is focused on the modulation of the immune system and activation of T cells to treat cancer. Its lead cancer immunotherapy product candidate is AE37, an Ii-Key-HER2 peptide vaccine for breast, prostate, and bladder cancer, which links its li-Key to a designated tumor antigen like HER-2 to activates the immune system to target specific cancer cells. NuGenerex Health LLC provides ancillary health services in the areas of eyecare, podiatry and chronic care management. NuGenerex Regenerative Medicine is focused on developing drugs, medical devices and therapeutics to improve treatment outcomes. Nugenerex Diagnostics, Inc. manufactures in-vitro medical diagnostic devices for both point of care and laboratory-based tests, primarily for infectious diseases.

Industry
-
Sector
-
Employees
0
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.